The association between hypovitaminosis D and metabolic syndrome: current understanding

Q Medicine

Clinical Lipidology Pub Date : 2015-12-01 DOI:10.2217/clp.15.38

I. Miñambres, J. L. Sánchez-Quesada, Antonio Pérez

引用次数: 7

Abstract

Abstract The metabolic syndrome and its components have been associated with hypovitaminosis D in many observational trials. Several mechanisms have been proposed to explain this relationship and include most conditions that are present in patients with the metabolic syndrome. A causal relationship of the association between the metabolic syndrome and hypovitaminosis D, however, has not been demonstrated, and the cardiovascular and metabolic benefits of vitamin D supplementation have not been confirmed. For the time being therefore, supplementation with vitamin D should only be recommended to maintain bone health and to avoid falls.

查看原文本刊更多论文

维生素D缺乏症与代谢综合征之间的关系:目前的认识

在许多观察性试验中，代谢综合征及其组成部分与维生素D缺乏症有关。已经提出了几种机制来解释这种关系，包括代谢综合征患者中存在的大多数情况。然而，代谢综合征和维生素D缺乏症之间的因果关系尚未得到证实，补充维生素D对心血管和代谢的益处也尚未得到证实。因此，就目前而言，补充维生素D应该只推荐用于保持骨骼健康和避免跌倒。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Lipidology 生物-生化与分子生物学

CiteScore

0.44

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal''s readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians. Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.